Skip to main content

Reactive Oxygen Species (ROS): Key Components in Cancer Immunotherapy

75kviews
REVIEW
7 December 2023
ROS regulation in gliomas: implications for treatment strategies
Yu-Chen Yang, 5 more and Li-Tian Ma

9,465 views

63 citations

4,078 views

10 citations

ORIGINAL RESEARCH
11 January 2024
Sublethal heat treatment enhances lactic acid uptake in macrophages via MCT1, leading to reduced paraspeckle formation and a subsequent decrease in macrophage pyroptosis
Zhuoyang Fan, 8 more and Rong Liu

3,621 views

6 citations

REVIEW
4 September 2023
Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions
Dandan Wu, 2 more and Bin Li
Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions
Glioma is the most common primary intracranial tumor in adults with poor prognosis. Current clinical treatment for glioma includes surgical resection along with chemoradiotherapy. However, the therapeutic efficacy is still unsatisfactory. The invasive nature of the glioma makes it impossible to completely resect it. The presence of blood-brain barrier (BBB) blocks chemotherapeutic drugs access to brain parenchyma for glioma treatment. Besides, tumor heterogeneity and hypoxic tumor microenvironment remarkably limit the efficacy of radiotherapy. With rapid advances of nanotechnology, the emergence of a new treatment approach, namely, reactive oxygen species (ROS)-based nanotherapy, provides an effective approach for eliminating glioma via generating large amounts of ROS in glioma cells. In addition, the emerging nanotechnology also provides BBB-crossing strategies, which allows effective ROS-based nanotherapy of glioma. In this review, we summarized ROS-based nanomedicine and their application in glioma treatment, including photodynamic therapy (PDT), photothermal therapy (PTT), chemodynamic therapy (CDT), sonodynamic therapy (SDT), radiation therapy, etc. Moreover, the current challenges and future prospects of ROS-based nanomedicine are also elucidated with the intention to accelerate its clinical translation.

6,127 views

25 citations

ORIGINAL RESEARCH
30 August 2023
Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis enhances antigen cross-presentation and antitumor efficacy through ROS production
Tingting Zhang, 6 more and Jinyao Li

4,060 views

19 citations

ORIGINAL RESEARCH
11 July 2023
A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
Hongxiang Liu, 11 more and Weide Zhong

3,900 views

5 citations

ORIGINAL RESEARCH
19 June 2023
Integrating machine learning algorithms to systematically assess reactive oxygen species levels to aid prognosis and novel treatments for triple -negative breast cancer patients
Juan Li, 2 more and Chihua Wu

3,622 views

13 citations

ORIGINAL RESEARCH
18 May 2023
Heart failure–related genes associated with oxidative stress and the immune landscape in lung cancer
Ruoshu Duan, 4 more and Jingjing Ren

4,704 views

13 citations